Legend Biotech

Legend Biotech CEO takes ‘close look at business’ amid geopolitical risk, M&A rumor
Fierce Pharma
Fri, 08/9/24 - 11:31 am
Legend Biotech
Pharma CEOs
Ying Huang
CAR-T
Carvykti
M&A
J&J’s CAR-T partner Legend Biotech reportedly receives buyout offer
Fierce Pharma
Mon, 07/15/24 - 11:20 pm
CAR-T
Legend Biotech
M&A
J&J, Legend's Carvykti shows CAR-T can extend lives in multiple myeloma
Fierce Pharma
Tue, 07/2/24 - 11:22 am
JNJ
Legend Biotech
CAR-T
Carvykti
Multiple Myeloma
clinical trials
ASCO24 preview: A look at some of the cancer meeting’s hottest abstracts
BioSpace
Fri, 05/31/24 - 11:03 am
ASCO 2024
Merus
JNJ
CAR-T
Legend Biotech
Pfizer
Genmab
Nanobiotix
Q&A: Legend Biotech CEO on whether Carvykti can meet expectations
Medical Marketing and Media
Mon, 04/15/24 - 11:16 am
Legend Biotech
Carvykti
mutliple myeloma
JNJ
Despite early death concerns, FDA advisers back J&J and Legend's Carvykti and BMS' Abecma for earlier myeloma
Fierce Pharma
Sun, 03/17/24 - 09:30 pm
JNJ
Legend Biotech
CAR-T
FDA
Carvykti
Abecma
FDA Adcomm to Tackle Complexity of CAR-T for Multiple Myeloma
BioSpace
Mon, 03/11/24 - 11:53 am
CAR-T
Multiple Myeloma
FDA
Bristol Myers Squibb
2seventy bio
Abecma
JNJ
Legend Biotech
Carvykti
J&J, Legend to Face Adcomm for Carvykti’s Push as Earlier Line MM Treatment
BioSpace
Wed, 01/24/24 - 10:40 am
JNJ
Legend Biotech
FDA
Carvykti
Multiple Myeloma
Novartis pays Legend $100M upfront to give solid tumor CAR-T the T-Charge treatment
Fierce Biotech
Mon, 11/13/23 - 11:55 am
Novartis
Legend Biotech
CAR-T
T-Charge
solid tumors
Legend Biotech to Showcase Leadership in Multiple Myeloma Treatment at the ASH 2023 Annual Meeting
BioSpace
Thu, 11/2/23 - 11:36 am
Legend Biotech
Multiple Myeloma
cilta-cel
ASH 2023
After launch limitations, Johnson & Johnson exec touts manufacturing progress on CAR-T drug Carvykti
Fierce Pharma
Wed, 10/18/23 - 07:44 pm
JNJ
Legend Biotech
Multiple Myeloma
CAR-T
Carvykti
cell therapy
3 Biotech Stocks Poised to Beat Q2 Earnings Estimates
Yahoo/Zacks.com
Mon, 08/14/23 - 11:15 am
earnings
Legend Biotech
Kodiak Sciences
Galera Therapeutics
J&J sees trial data supporting earlier CAR-T use in multiple myeloma
BioPharma Dive
Mon, 06/5/23 - 10:12 am
ASCO 2023
JNJ
Legend Biotech
Carvykti
CAR-T
Multiple Myeloma
J&J, Legend's Carvykti cut risk of progression or death by whopping 74% in earlier myeloma, leaked abstract shows
Fierce Pharma
Wed, 04/19/23 - 11:24 am
CAR-T
Bristol Myers Squibb
JNJ
Legend Biotech
AACR
Multiple Myeloma
Carvykti
Abecma
Johnson & Johnson shelves Carvykti's UK launch amid manufacturing shortfalls
Fierce Pharma
Wed, 03/15/23 - 09:27 pm
JNJ
Legend Biotech
CAR-T
Carvykti
J&J, Legend’s cancer cell therapy has early success in key clinical trial
BioPharma Dive
Mon, 01/30/23 - 10:27 am
JNJ
Legend Biotech
Carvykti
Multiple Myeloma
clinical trials
cell therapy
Sales of J&J, Legend cell therapy plateau amid production challenges
BioPharma Dive
Wed, 01/25/23 - 10:57 pm
JNJ
Legend Biotech
gene therapy
Carvykti
Multiple Myeloma
Gilead lands new cell therapy for Kite in $225M Arcellx deal
Fierce Biotech
Fri, 12/9/22 - 10:37 am
Gilead Sciences
Kite Pharma
Arcellx
clinical trials
Multiple Myeloma
cell therapy
JNJ
Legend Biotech
FDA approves Legend Biotech’s IND application for lung cancer therapy trial
Clinical Trials Arena
Tue, 11/22/22 - 10:58 am
FDA
Legend Biotech
LB2102
small cell lung cancer
J&J partner Legend Biotech looks to raise $250M amid Carvykti rollout, global expansion
Fierce Pharma
Wed, 07/27/22 - 10:28 am
JNJ
Legend Biotech
Carvykti
CAR-T

Pages